Impairments of HIPK2, the master p53 regulator, frequently detected in well-differentiated thyroid carcinomas, are responsible for the occurrence of Galectin-3 overexpression observed in these types of cancer [71]. This evidence concerns the gene TP53 and thyroid gland carcinoma.